Colorectal Surgery Market Report 2026

The colorectal surgery market size has grown rapidly in recent years. It will grow from $23.83 billion in 2025 to $26.35 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing prevalence of colorectal disorders, rising colorectal cancer incidence, expansion of surgical specialty centers, growing adoption of laparoscopic procedures, advancements in surgical device technology.

The colorectal surgery market size is expected to see rapid growth in the next few years. It will grow to $38.98 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for robotic colorectal procedures, rising focus on early disease detection and intervention, expansion of ambulatory surgical centers, growing investments in surgical innovation, increasing preference for minimally invasive treatment options. Major trends in the forecast period include increasing adoption of minimally invasive surgical techniques, rising use of advanced endoscopic systems, growing integration of robotic-assisted surgery, expansion of single-use surgical instruments, enhanced focus on surgical precision and outcomes.

The rising incidence of colorectal cancer is expected to drive growth in the colorectal surgery market. Colorectal cancer is a malignant condition that develops in the colon or rectum, often beginning as benign polyps that may become cancerous over time. The increase in cases is linked to lifestyle factors such as poor diet and sedentary behavior, which elevate the risk of developing the disease. Colorectal surgery treats cancer by removing malignant tissues and affected sections of the colon or rectum, improving patient outcomes and reducing the risk of disease progression. For example, in July 2025, Cancer Australia reported approximately 15,542 new colorectal cancer cases in 2024, with an estimated 5,239 deaths in 2023. This rising incidence is therefore fueling the colorectal surgery market.

Companies in the colorectal surgery market are advancing technologies such as AI-enhanced intraoperative ultrasound to improve surgical precision and patient outcomes. This approach integrates real-time intraoperative ultrasound imaging with artificial intelligence algorithms to enhance tumor detection, optimize resection margins, reduce complications, shorten operation times, and improve overall procedural accuracy. For instance, in June 2025, US-based GE HealthCare launched the bkActiv S series, a next-generation intraoperative ultrasound system designed to improve imaging precision in colorectal and pelvic floor procedures. Enhanced visualization during surgery supports minimally invasive interventions, better patient outcomes, and the expansion of nonsurgical colorectal care capabilities.

In December 2023, Ireland-based Medtronic plc partnered with Singapore-based Cosmo Intelligent Medical Devices to advance AI-driven endoscopy technologies and strengthen innovation in gastrointestinal care. This partnership aims to improve colorectal diagnostics and surgical planning through AI-assisted polyp detection, enhancing procedural efficiency and patient outcomes. Cosmo Intelligent Medical Devices provides AI-assisted colonoscopy platforms and colorectal diagnostic tools designed for early detection and intervention in colorectal care.

Major companies operating in the colorectal surgery market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Olympus Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Steris plc, Karl Storz SE & Co. KG, Cook Medical LLC, Conmed Corporation, Applied Medical Resources Corporation, Richard Wolf GmbH, Laborie Medical Technologies, CMR Surgical Ltd, B. Braun Melsungen AG, Boston Scientific Corporation, Fujifilm Holdings Corporation, Getinge AB, Medline Industries Inc., Ethicon Inc.

North America was the largest region in the colorectal surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the colorectal surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the colorectal surgery market by increasing costs of imported endoscopic devices, electrosurgical systems, robotic components, surgical staplers, and imaging equipment. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-precision medical devices, while Asia-Pacific faces higher costs for advanced surgical technology imports. These tariffs are increasing procedure costs and capital expenditure for healthcare providers. However, they are also encouraging local manufacturing of surgical instruments, regional device assembly, and innovation in cost-effective colorectal surgical solutions.

The colorectal surgery market research report is one of a series of new reports that provides colorectal surgery market statistics, including colorectal surgery industry global market size, regional shares, competitors with a colorectal surgery market share, detailed colorectal surgery market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal surgery industry. This colorectal surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Colorectal surgery is a medical specialty dedicated to diagnosing, treating, and surgically managing diseases and disorders of the colon, rectum, and anus. It covers a variety of procedures for conditions such as colorectal cancer, diverticulitis, inflammatory bowel diseases like Crohn’s disease and ulcerative colitis, hemorrhoids, anal fissures, and fistulas.

The main products used in colorectal surgery include endoscopes, electrosurgical devices, visual systems and handheld instruments, sealing and stapling devices, ligation clips and dilators, cutting instruments such as cutters and shears, and other surgical accessories. Endoscopes are medical tools used to visually inspect the interior of hollow organs or body cavities. Surgical procedures include right hemicolectomy, left hemicolectomy, subtotal hemicolectomy, low anterior resection, abdomino-perineal resection, and others. Indications for these surgeries include colon polyps, Crohn’s disease, colorectal cancer, colitis, irritable bowel syndrome (IBS), and other related conditions. The primary end-users of these products are hospitals, ambulatory surgical centers, specialty clinics, and similar healthcare facilities.

The colorectal surgery market consists of revenues earned by entities through trans anal surgery, endoscopic procedures, and diverticulitis surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The colorectal surgery market also includes the sale of robotic surgery systems, hemostasis and suturing devices, and imaging and navigation equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.